(E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride

C30H30ClN3O2 — CID 146051501

IUPAC(E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride
SMILESCOc1ccccc1Nc1c2c(nc3ccc(NC(=O)/C=C/c4ccc(C)cc4)cc13)CCCC2.Cl
InChIInChI=1S/C30H29N3O2.ClH/c1-20-11-13-21(14-12-20)15-18-29(34)31-22-16-17-26-24(19-22)30(23-7-3-4-8-25(23)32-26)33-27-9-5-6-10-28(27)35-2;/h5-6,9-19H,3-4,7-8H2,1-2H3,(H,31,34)(H,32,33);1H/b18-15+;
InChIKeyMQKBOUAESCYYCY-FLNCGGNMSA-N
MW500.04 g/mol
LogP7.25
Rot. Bonds6

About (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride

(E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride (PubChem CID 146051501) has the molecular formula C30H30ClN3O2 and a molecular weight of 500.04 g/mol. Its IUPAC name is (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride.

Molecular Properties

Compound Name(E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride
PubChem CID146051501
Molecular FormulaC30H30ClN3O2
Molecular Weight500.04 g/mol
Exact Mass499.20
IUPAC Name(E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride
SMILESCOc1ccccc1Nc1c2c(nc3ccc(NC(=O)/C=C/c4ccc(C)cc4)cc13)CCCC2.Cl
InChIInChI=1S/C30H29N3O2.ClH/c1-20-11-13-21(14-12-20)15-18-29(34)31-22-16-17-26-24(19-22)30(23-7-3-4-8-25(23)32-26)33-27-9-5-6-10-28(27)35-2;/h5-6,9-19H,3-4,7-8H2,1-2H3,(H,31,34)(H,32,33);1H/b18-15+;
InChIKeyMQKBOUAESCYYCY-FLNCGGNMSA-N
XLogP7.25
TPSA63.25 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500500.04
LogP ≤ 57.25
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride?
The IUPAC name of (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride (CID 146051501) is (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride.
What is the SMILES notation for (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride?
The canonical SMILES for (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride is COc1ccccc1Nc1c2c(nc3ccc(NC(=O)/C=C/c4ccc(C)cc4)cc13)CCCC2.Cl.
What is the InChIKey of (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride?
The InChIKey is MQKBOUAESCYYCY-FLNCGGNMSA-N. The full InChI is InChI=1S/C30H29N3O2.ClH/c1-20-11-13-21(14-12-20)15-18-29(34)31-22-16-17-26-24(19-22)30(23-7-3-4-8-25(23)32-26)33-27-9-5-6-10-28(27)35-2;/h5-6,9-19H,3-4,7-8H2,1-2H3,(H,31,34)(H,32,33);1H/b18-15+;.
What are the key properties of (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride?
(E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride has a molecular weight of 500.04 g/mol, XLogP of 7.25, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-N-[9-(2-methoxyanilino)-5,6,7,8-tetrahydroacridin-2-yl]-3-(4-methylphenyl)prop-2-enamide;hydrochloride is sourced from PubChem (CID 146051501), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).